Skip to main content

Table 4 Multivariate Analyses of overall survival for patients with advanced non-small cell lung cancer: age < 70 years versus ≥70 years

From: Improved uptake and survival with systemic treatments for metastatic non-small cell lung cancer: younger versus older adults

 

Age <70 years

(n = 1691)

Age ≥70 years

(n = 1634)

 

HR (95% CI)

p-value

HR (95% CI)

p-value

Diagnosis Age

2009

2011

2015

2017

Reference

0.89 (0.76–1.03)

0.82 (0.71–0.95)

0.88 (0.75–1.02)

0.121

0.008

0.085

Reference

1.00 (0.86–1.18)

0.97 (0.84–1.13)

0.87 (0.75–1.02)

0.958

0.714

0.082

Sex

Male versus Female

1.28 (1.16–1.42)

< 0.001

1.15 (1.04–1.28)

0.008

ECOG at Diagnosis

PS 0–1

PS ≥2

Unknown

Reference

2.00 (1.79–2.23)

2.13 (1.80–2.51)

< 0.001

Reference

2.14 (1.89–2.41)

1.86 (1.56–2.22)

< 0.001

SCS

≥9 versus < 9

1.05 (0.94–1.18)

0.364

0.96 (0.86–1.08)

0.964

Smoking History

Never

Current/Former

Unknown

Reference

1.55 (1.34–1.80)

1.72 (1.09–2.70)

< 0.001

0.019

Reference

1.53 (1.30–1.81)

1.66 (1.21–2.28)

< 0.001

0.002

  1.  h = Hazard Ratio; CI = Confidence Interval; ECOG = Eastern Cooperative Oncology Group; PS = Performance Status; SCS = Simplified Comorbidity Score